News
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...
DR NELLY KAMWALEKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 diabetes and obesity. Two drugs, Semaglutide and Tirzepatide ...
Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...
WEIGHT loss drugs can sound like a magical quick fix to overeating and constant hunger pangs. But not everyone is eligible ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatment <li /> Combination of oral PL7737 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results